Net sales rose to 2,533 KSEK in H1 2024, but the group posted a net loss of -20,445 KSEK. Strategic actions included a new dividend policy, divestment of Neola Medical, and distribution of TEQCool shares, while portfolio companies made notable operational progress.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.